VoIce Changes and Heart Failure
Do VoIce Changes Predict Heart Failure
1 other identifier
observational
12
0 countries
N/A
Brief Summary
This is an observational, single center study to evaluate if acoustic and accelerometer-based measures of voice and speech have sufficient precision to detect a change in lung fluid status for patients with confirmed acute heart failure syndrome with pulmonary congestion. The study shall be conducted in concordance with the United States FDA regulations for a non-significant risk study. Patients admitted for acute heart failure syndrome with pulmonary congestion with an expected stay greater than 3 to 4 days, who are willing and able to sign an informed consent, and who meet all inclusion/exclusion criteria, as identified by the clinical investigator, will be enrolled in the study. Results of this study will evaluate the sensitivity of voice and speech measures in detecting changes in lung fluid status in a symptomatic population. Up to 12 subjects will be enrolled to comparatively evaluate the voice outcome measures in this pilot study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2015
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 18, 2015
CompletedFirst Posted
Study publicly available on registry
September 22, 2015
CompletedStudy Start
First participant enrolled
October 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedSeptember 22, 2015
September 1, 2015
5 months
September 18, 2015
September 18, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Relationship between change in pitch and change in total body water
correlation of change in fundamental frequency with change in weight
10 days
Secondary Outcomes (2)
relationship between change in pitch and change in NTproBNP
10 days
correlation in change in pitch with change in dyspnea visual analog scale (DVAS)
10 days
Study Arms (1)
Heart failure syndrome & pulmonary congestion
Patients who are admitted for inpatient management with acute heart failure syndrome with pulmonary congestion who require intravenous diuretics are potential candidates for the study and shall be screened for suitability based on the inclusion and exclusion criteria.
Eligibility Criteria
Patients with acute heart failure syndromes admitted for inpatient management meeting inclusion and exclusion criteria will be asked to consent for the study.
You may qualify if:
- \> 18 years
- Prior diagnosis of heart failure with daily use of loop diuretic
- Must be identified within 48 hrs of admission
- Diagnosis of acute Congestive Heart Failure (CHF) as defined by at least one symptom or one clinical sign
- Believed to be \> 10 lbs above target weight
- Anticipated need for iv loop diuretic for at least 48 hrs
You may not qualify if:
- Inability to perform VA
- Respiratory infection
- Significant pulmonary disease requiring the use of inhaler bronchodilators or steroids
- Anticipate need for vasoactive agent or ultrafiltration
- Systolic BP \< 90 mmHg
- Serum Cr \> 3 on admission or requirement for dialysis
- Hemodynamically significant arrhythmias
- Acute Coronary Syndrome (ACS) within 4 weeks
- Hypertrophic Obstructive Cardiomyopathy (HOCM)
- Severe stenotic valve disease
- Complex congenital heart disease
- Sepsis
- Active smoking within 1 year
- O2 saturation less than 92% on room air
- History of diagnosed vocal cord pathology / dysfunction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marc Semigran, MD
Massachusetts General Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physician investigator
Study Record Dates
First Submitted
September 18, 2015
First Posted
September 22, 2015
Study Start
October 1, 2015
Primary Completion
March 1, 2016
Study Completion
March 1, 2016
Last Updated
September 22, 2015
Record last verified: 2015-09